Structure of the molybdenum site of dimethyl sulfoxide reductase

Journal of the American Chemical Society

Volumn 121, Issue 6, 1999, Pages 1256-1266

  George, Graham N ^a   Hilton, James ^b   Temple, Carrie ^b   Prince, Roger C ^c   Rajagopalan, K V ^b  

^a SLAC NATIONAL ACCELERATOR LABORATORY   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c EXXONMOBIL UPSTREAM RESEARCH COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIMETHYL SULFIDE; DITHIONITE; MOLYBDENUM; OXIDOREDUCTASE; OXYGEN;

ARTICLE; CATALYSIS; CHEMICAL STRUCTURE; ELECTROCHEMICAL ANALYSIS; ELECTRON SPIN RESONANCE; ENZYME ACTIVE SITE; NONHUMAN; RHODOBACTER SPHAEROIDES; SITE DIRECTED MUTAGENESIS;

RHODOBACTER SPHAEROIDES;

EID: 0033576980     PISSN: 00027863     EISSN: None     Source Type: Journal    
DOI: 10.1021/ja982843k     Document Type: Article

References (81)

1. (a) Rajagopalan, K. V. Adv. Enzymol. Relat. Areas Mol. Biol. 1991, 64, 215-290.
2. (b) Rajagopalan, K. V.; Johnson, J. L. J. Biol. Chem. 1992, 267, 10199-10202.
3. (a) Kisker, C.; Shindelin, H.; Rees, D. C. Annu. Rev. Biochem. 1997, 66, 233-267.
4. (b) Hille, R. Chem. Rev. 1996, 96, 6, 2757-2816.
5. (c) Johnson, M. K.; Rees, D. C.; Adams, M. W. W. Chem. Rev. 1996, 96, 6, 2817-2859.
6. (d) Hille, R. Biochim. Biophys. Acta 1994, 1184, 143-169.
7. (e) Enemark, J. H.; Young, C. G. Adv. Inorg. Chem., 1993, 40, 1-88.
8. (f) Wooton, J. C.; Nicolson, R. E.; Cock, M. J.; Walters, D. E.; Burke, J. F.; Doyle, W. A.; Bray, R. C. Biochim. Biophys. Acta 1993, 1057, 157-185.
9. (g) Enemark, J. H.; Young, C. G. Adv. Inorg. Chem. 1993, 40, 1-88.
10. 7
11. Rosner, B. M.; Schink, B. J. Bacteriol. 1995, 177, 5767-5772.
12. Khangulov, S. V.; Gladyshev, V. N.; Dismukes, G. C.; Stadtman, T. C. Biochemistry 1998, 37, 3518-3528.
13. George, G. N.; Colangelo, C. M.; Dong, J.; Scott, R. A.; Khangulov, S. V.; Gladyshev, V. N.; Stadtman, T. C. J. Am. Chem. Soc. 1998, 120, 1267-1273.
14. George, G. N.; Moura, I.; Moura, J. J., Unpublished observations.
15. (a) Romão, M. J.; Archer, M.; Moura, I.; Moura, J. J. G.; LeGall, J.; Engh, R.; Schneider, M.; Hof, P.; Huber, R. Science 1995, 270, 1170-1176.
16. (b) Huber, R.; Hof, P.; Duarte, R. O.; Moura, J. J. G.; Moura, I.; Liu, M.-H.; LeGall, J.; Hille, R.; Archer, M.; Romão, M. J. Proc. Natl. Acad. Sci. U.S.A. 1996, 93, 8846-8851.
17. (c) Boyington, J. C.; Gladyshev, V. N.; Khangalov, S. V.; Stadtman, T. C.; Sun, P. D. Science 1997, 275, 1305-1308.
18. (d) Kisker, C.; Schindelin, H.; Pacheco, A.; Wehbi, W. A.; Garrett, R. M.; Rajagopalan, K. V.; Enemark, J. E.; Rees, D. C. Cell 1997, 91, 1-20.
19. Schindelin, H.; Kisker, C.; Hilton, J.; Rajagopalan, K. V.; Rees, D. C. Science 1996, 272, 1615-1621.
20. Schneider, F.; Löwe, J.; Huber, R.; Schindelin, H.; Kisker, C.; Knäblein, J. J. Mol. Biol. 1996, 263, 53-69.
21. McAlpine, A. S.; McEwan, A. G.; Shaw, A. L.; Bailey, S. J. Biol. Inorg. Chem. 1997, 2, EXAFS 690-701.
22. McAlpine, A. S.; McEwan, A. G.; Bailey, S. J. Mol. Biol. 1998, 275, 613-623.
23. George, G. N.; Hilton, J.; Rajagopalan, K. V. J. Am. Chem. Soc. 1996, 118, 1113-1117.
24. Baugh, P. E.; Garner, C. D.; Charnock, J. M.; Collison, D.; Davies, E. S.; McAlpine, A. S.; Bailey, S.; Lane, I.; Hanson, G. R.; McEwan A. G. J. Biol. Inorg. Chem. 1997, 2, 634-643.
25. (a) Gruber, S.; Kilpatrick, L.; Bastian, N. R.; Rajogopalan, K. V.; Spiro, T. G. J. Am. Chem. Soc. 1990, 112, 8179-8180.
26. (b) Kilpatrick, L.; Rajagopalan, K. V.; Hilton, J.; Bastian, N. R.; Steifel, E. I.; Pilato, R. S.; Spiro, T. G. Biochemistry 1995, 34, 3032-3039.
27. Garton, S. D.; Hilton, J.; Hiroyuki, O.; Crouse, B. R.; Rajagopalan, K. V.; Johnson, M. K. J. Am. Chem. Soc. 1997, 119, 12906-12916.
28. Benson, N.; Farrar, J. A.; McEwan, A. G.; Thomson, A. J. FEBS Lett. 1992, 307, 169-172.
29. Finnegan, M. G.; Hilton, J.; Rajagopalan, K. V.; Johnson, M. K. Inorg. Chem. 1993, 32, 2616-2617.
30. Bastian, N. R.; Kay, C. J.; Barber, M. J.; Rajagopalan, K. V. J. Biol. Chem. 1991, 266, 45-51.
31. Bennet B.; Benson, N.; McEwan, A. G.; Bray, R. C. Eur. J. Biochem. 1994, 255, 321-331.
32. Schindelin, H.; Kisker, C.; Rees, D. C. J. Biol. Inorg. Chem. 1997, 2, 773-781.
33. Hilton, J.; Rajagopalan, K. V. Arch. Biochem. Biophys. 1996, 325, 139-143.
34. Hilton, J. C.; Rajagopalan, K. V. Biochim. Biophys. Acta, Gene Struct. Expr. 1996, 1294, 111-114.
35. George, G. N.; Prince, R. C.; Kipke, C. A.; Sunde, R. A.; Enemark, J. E. Biochem. J. 1988, 256, 307-309.
36. Dutton, P. L. Methods Enzymol. 1978, 24, 431-446
37. Clark, W. M. Oxidation-Reduction Potentials of Organic Systems; Williams and Wilkins: Baltimore, MD, 1960.
38. Cramer, S. P.; Tench, O.; Yocum, M.; George, G. N. Nucl. Instrum. Methods Phys. Res. 1988, A266, 586-591.
39. The EXAFSPAK program suite was developed by G.N.G. and is available from http://ssrl.slac.stanford.edu/exafspak.html.
40. George, G. N.; Kipke, C. A.; Prince, R. C.; Sunde, R. A.; Enemark, J. H.; Cramer, S. P. Biochemistry 1989, 28, 5075-5080.
41. (a) Rehr, J. J.; Mustre de Leon, J.; Zabinsky, S. I.; Albers, R. C. J. Am. Chem. Soc. 1991, 113, 5135-5140.
42. (b) Mustre de Leon, J.; Rehr, J. J.; Zabinsky, S. I.; Albers, R. C. Phys. Rev. 1991, B44, 4146-4156.
43. E.g., see: George, G. N.; Bray, R. C. Biochemistry 1988, 27, 3603-3609.
44. E.g., see: Balagoparalkrishna, C.; Kimbrough, J. T.; Westmoreland, D. T. Inorg. Chem. 1996, 35, 7758-7768.
45. Trieber, C. A.; Rothery, R. A.; Weiner, J. H. J. Biol. Chem. 1996, 271, 27339-27345.
46. Cleland, W. E.; Barnhardt, I. T. M.; Yamanouchi, K.; Collison, D.; Mabbs, F. E.; Ortega, R.; Enemark, J. H. Inorg. Chem. 1987, 26, 1017-1025.
47. Bray, R. C.; Gutteridge, S. Biochemistry 1982, 21, 5992-5999.
48. Greenwood, R. J.; Wilson, G. L.; Pilbrow, J. R.; Wedd, A. G. J. Am. Chem. Soc. 1993, 115, 5385-5392.
49. Goodman, B. A.; Raynor, J. B. Adv. Inorg. Chem. Radiochem. 1970, 13, 135-362.
50. Kutzler, F. W.; Natoli, C. R.; Misemer, D. K.; Doniach, S.; Hodgson. K. O. J. Chem. Phys. 1980, 73, 3274-3288.
51. 2, with the lower values resulting from the data sets of highest quality.
52. 2 weighting is used (from 0.231 to 0.160). In either case, the intensity of the Mo=O peak in the EXAFS Fourier transform is only reproduced with two Mo=O ligands.
53. George, G. N.; Prince, R. C.; Mukund, S.; Adams, M. W. W. J. Am. Chem. Soc. 1992, 114, 4, 3521-3523.
54. George, G. N.; Prince, R. C.; Mukund, S.; Adams, M. W. W. Unpublished results.
55. (a) Kopwillem, A. Acta Chem. Scand. 1972, 26, 2941.
56. (b) Berg, J. M.; Hodgson, K. O. Inorg. Chem. 1980, 19, 2180-2181.
57. (a) Brown, I. D.; Allermat, D. Acta Crystallogr. 1985, B41, 244-247.
58. (b) Brese, N. E.; O'Keeffe, M. Acta Crystallogr. 1991, B47, 192-197.
59. Thorp, H. H. Inorg. Chem. 1992, 31, 1583-1588.
60. We note that discrimination of four Mo-S ligands from five Mo-S ligands is bordering on the limts of accuracy of the technique, and our coordination numbers discussed above are thus somewhat tentative.
61. George, G. N.; Bray, R. C.; Morpeth, F. F.; Boxer, D. H. Biochem. J. 1985, 227, 925-931.
62. George, G. N.; Turner, N. A.; Bray, R. C.; Morpeth, F. F.; Boxer, D. H.; Cramer, S. P. Biochem. J. 1989, 259, 693-700.
63. Cramer, S. P.; Solomonson, L. P.; Adams, M. W. W.; Mortenson, L. E. J. Am. Chem. Soc. 1984, 106, 1467-1471.
64. 19F hyperfine structure could arise primarily from dipole-dipole splittings from flouride bound in an anion binding pocket.
65. 52,34
66. Joyner, R. W.; Martin, K. J.; Meehan, P. J. Phys. C. Solid State Phys. 1987, 20, 4005-4012.
67. Sachs, L. Applied Statistics, 2nd ed.; Springer-Verlag: New York, Berlin, Heidelberg, Tokyo, 1984.
68. George, G. N. J. Biol. Inorg. Chem. 1997, 2, 790-796.
69. 10
70. Dirand, J.; Ricard, L.; Weiss, R. Transition Met. Chem. 1975, 1, 2-5.
71. Stiefel, E. I. In Comprehensive Coordination Chemistry; Wilkinson, G., Ed.; Pergamon Press: Oxford, U.K., 1987; pp 1375-1420.
72. 2(tetra-p-tolylporphrinate) is 95.1° (Menzen, B. F.; Bonnet, M. C.; Ledon, H. J. Inorg. Chem. 1980, 19, 2061-2066). In this case strong steric constraints force a smaller than normal bond angle and the large deviations of the porphyrin ring from planarity illustrate the contortions that can be tolerated to maintain the cis dioxo geometry.
73. Rees, D. C.; Hu, Y.; Kisker, C.; Schindelin, H. J. Chem. Soc., Dalton Trans. 1997, 3909-3914.
74. Schindelin H. Personal communication.
75. Sulfenic acids (R-S-OH) are chemically unstable and are not known as free acids, but are known mostly from their derivatives, e.g. sulfenyl halides (R-S-Cl). Nevertheless, biological sulfenic acids are known, and in particular a cysteine sulfenic acid is the redox center in streptococcal NADH peroxidase (Stehle, T.; Ahmed, S. A.; Claiborne, A.; Schultz, G. E. J. Mol. Biol. 1991, 221, 1325-1344). The possibility of derivitization of a cofactor dithiolene might provide an expanation for the observations of Bastian et al. (Bastian, N. R.; Foster, M. J. P.; Pope, J. C. Biofactors 1995, 5, 5-10) of modified Mo(V) EPR and optical spectra in the presence of NO and related compounds.
76. Sulfenic acids (R-S-OH) are chemically unstable and are not known as free acids, but are known mostly from their derivatives, e.g. sulfenyl halides (R-S-Cl). Nevertheless, biological sulfenic acids are known, and in particular a cysteine sulfenic acid is the redox center in streptococcal NADH peroxidase (Stehle, T.; Ahmed, S. A.; Claiborne, A.; Schultz, G. E. J. Mol. Biol. 1991, 221, 1325-1344). The possibility of derivitization of a cofactor dithiolene might provide an expanation for the observations of Bastian et al. (Bastian, N. R.; Foster, M. J. P.; Pope, J. C. Biofactors 1995, 5, 5-10) of modified Mo(V) EPR and optical spectra in the presence of NO and related compounds.
77. 2-phenylsulfinyl ligands has been reported (Vasyutinskaya, E. A.; Eremenko, I. L.; Pasynskii, A. A.; Yanovskii, A. I.; Struchkov, Yu. T. Zh. Neorg. Khim. 1991, 36, 1707-1709).
78. Pickering, I. J.; Prince, R. C.; Divers, T.; George, G. N. FEBS Lett. accepted for publication.
79. Schultz, B. E.; Hille, R.; Holm, R. H. J. Am. Chem. Soc. 1995, 117, 827-828.
80. Rappe, A. K.; Goddard, W. A. J. Am. Chem. Soc. 1982, 104, 3287-3294.
81. We note that there is a clear difference between chemically unusual or novel and chemically unreasonable; the active sites of very many metalloproteins can be considered to be chemically unusual.